Fly-E Group, Inc.
FLYE Nasdaq Motor Vehicles & Passenger Car Bodies Financials FY2023βFY2026
What Fly-E Group, Inc. does
No business description yet.
- Legal name
- Fly-E Group, Inc.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K Β· Jul 23, 2026
- Accession Β· CIK
- 0001213900-26-080973
0001975940
Revenue and margins
Fly-E Group, Inc. had $19.1M of revenue in fiscal 2026, down 25.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$13.9M in fiscal 2026, β73.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Fly-E Group, Inc. returned β to shareholders in fiscal 2026. The diluted share count rose 358.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Fly-E Group, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Cash and short-term investments | $0.4M | $1.4M | $0.8M | $0.3M |
| Debt incl. finance leases | $0.4M | $1.2M | $5.3M | $6.0M |
| Net debt / EBITDA | 0.0x | β0.1x | β | β |
| Debt / equity | 0.2x | 0.2x | 0.5x | 0.3x |
| Interest coverage | 23.0x | 21.4x | β11.2x | β |
| Current ratio | 1.1x | 1.0x | 1.1x | 2.5x |
| Quick ratio | 0.3x | 0.4x | 0.6x | 2.1x |
| Total assets | $17.3M | $29.0M | $33.7M | $29.5M |
| Total liabilities | $14.8M | $22.2M | $23.9M | $12.1M |
| Shareholders' equity | $2.5M | $6.8M | $9.8M | $17.4M |
| Net debt (β = net cash) | $0.1M | β$0.2M | $4.5M | $5.7M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 3 / 9 | 1 / 9 |
| Accruals ratio | β2.2% | β10.4% | 15.2% | 14.5% |
| Altman Z'' | 1.78 | 1.65 | β0.31 | 1.16 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $21.8M | $32.2M | $25.4M | $19.1M |
| Net interest income | β$0.1M | β$0.2M | β$0.4M | β$1.8M |
| Gross profit | $8.3M | $13.1M | $10.5M | $4.7M |
| Research and development | β | $0.3M | $0.5M | $0.3M |
| Operating income | $2.3M | $3.3M | β$4.6M | β$6.4M |
| Interest expense | $0.1M | $0.2M | $0.4M | β |
| Pretax income | $2.2M | $3.1M | β$5.0M | β$8.9M |
| Income tax | $0.8M | $1.2M | $0.3M | $0.3M |
| Net income | $1.4M | $1.9M | β$5.3M | β$9.3M |
| Diluted EPS | β | β | β$21.95 | β$8.38 |
| Diluted shares | 0.02B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||
| Cash from operations | $1.8M | $4.3M | β$10.1M | β$13.8M |
| Capital expenditure | β | $1.3M | $1.6M | $0.1M |
| Free cash flow | β | $3.1M | β$11.7M | β$13.9M |
| Depreciation and amortization | $0.1M | $0.3M | $0.6M | $0.7M |
| Acquisitions | β | $1.3M | β | β |
| Balance sheet | ||||
| Cash and short-term investments | $0.4M | $1.4M | $0.8M | $0.3M |
| Total debt | $0.4M | $1.2M | $5.3M | $6.0M |
| Current assets | $5.5M | $8.1M | $14.0M | $16.8M |
| Current liabilities | $4.9M | $7.8M | $12.7M | $6.8M |
| Inventory | $3.8M | $5.4M | $6.4M | $2.3M |
| Property and equipment, net | $0.8M | $1.8M | $7.3M | $5.8M |
| Intangible assets | β | $0.0M | $0.5M | $0.4M |
| Total assets | $17.3M | $29.0M | $33.7M | $29.5M |
| Total liabilities | $14.8M | $22.2M | $23.9M | $12.1M |
| Shareholders' equity | $2.5M | $6.8M | $9.8M | $17.4M |
| Margins | ||||
| Gross margin | 38.1% | 40.7% | 41.1% | 24.4% |
| Operating margin | 10.6% | 10.1% | β17.9% | β33.8% |
| EBITDA margin | 11.3% | 11.0% | β15.5% | β30.0% |
| Net margin | 6.3% | 5.9% | β20.8% | β48.6% |
| FCF margin | β | 9.5% | β46.0% | β73.0% |
| Net interest share of revenue | β0.5% | β0.5% | β1.6% | β9.5% |
| Returns | ||||
| Return on capital | 58.9% | 32.2% | β25.2% | β22.0% |
| Return on capital employed | 18.7% | 15.4% | β21.7% | β28.4% |
| Return on equity | 55.1% | 40.8% | β63.7% | β67.9% |
| Return on assets | 8.0% | 8.2% | β16.9% | β29.3% |
| Return on tangible equity | 55.1% | 28.1% | β56.8% | β54.4% |
| Growth | ||||
| Revenue growth | β | 47.9% | β21.0% | β25.0% |
| Net income growth | β | 37.5% | β379.2% | β |
| FCF growth | β | β | β482.7% | β |
| Share count change | β | β80.0% | β94.5% | 358.1% |
| Financial health | ||||
| Net debt / EBITDA | 0.0x | β0.1x | β | β |
| Debt / equity | 0.2x | 0.2x | 0.5x | 0.3x |
| Interest coverage | 23.0x | 21.4x | β11.2x | β |
| Current ratio | 1.1x | 1.0x | 1.1x | 2.5x |
| Quick ratio | 0.3x | 0.4x | 0.6x | 2.1x |
| Capital allocation | ||||
| Capex / revenue | β | 3.9% | 6.4% | 0.4% |
| Quality scores | ||||
| Piotroski F-score | β | 5.0 | 3.0 | 1.0 |
| Altman Z'' | 1.8 | 1.6 | β0.3 | 1.2 |
| Accruals ratio | β2.2% | β10.4% | 15.2% | 14.5% |
Source: SEC EDGAR XBRL filings (CIK 0001975940). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.